Predictive Biomarkers of Immune Checkpoint Inhibitors-Related Toxicities

Ya Xu(Wuhan University), Bicheng Zhang(University of Electronic Science and Technology of China), Bo Zhu(Huaian First People’s Hospital), Jun Wang(Shenzhen Bao'an District People's Hospital), Yang Fu(First Affiliated Hospital of Zhengzhou University)
Frontiers in Immunology
October 6, 2020
10.3389/fimmu.2020.02023
Cited by 82

Related Papers

T-cell exhaustion in the tumor microenvironment
|Cell Death and Disease|2015|1.1k
Clinical characteristics of 82 cases of death from COVID-19
|PLoS ONE|2020|594
Immune Phenotyping Based on the Neutrophil-to-Lymphocyte Ratio and IgG Level Predicts Disease Severity and Outcome for Patients With COVID-19
|Frontiers in Molecular Biosciences|2020|497
Prognostic Value of C-Reactive Protein in Patients With Coronavirus 2019
|Clinical Infectious Diseases|2020|458
Donafenib Versus Sorafenib in First-Line Treatment of Unresectable or Metastatic Hepatocellular Carcinoma: A Randomized, Open-Label, Parallel-Controlled Phase II-III Trial
|Journal of Clinical Oncology|2021|417